{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:49:07Z","timestamp":1793886547650,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/I\/16\/2\/502719"],"award-info":[{"award-number":["IA\/I\/16\/2\/502719"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epithelial splicing regulatory protein 1 (ESRP1) is an RNA binding protein that governs the alternative splicing events related to epithelial phenotypes. ESRP1 contributes significantly at different stages of cancer progression. ESRP1 expression is substantially elevated in carcinoma in situ compared to the normal epithelium, whereas it is drastically ablated in cancer cells within hypoxic niches, which promotes epithelial to mesenchymal transition (EMT). Although a considerable body of research sought to understand the EMT-associated ESRP1 downregulation, the regulatory mechanisms underlying ESRP1 upregulation in primary tumors remained largely uncharted. This study seeks to unveil the regulatory mechanisms that spatiotemporally fine-tune the ESRP1 expression during breast carcinogenesis. Our results reveal that an elevated expression of transcription factor E2F1 and increased CpG hydroxymethylation of the E2F1 binding motif conjointly induce ESRP1 expression in breast carcinoma. However, E2F1 fails to upregulate ESRP1 despite its abundance in oxygen-deprived breast cancer cells. Mechanistically, impelled by the hypoxia-driven reduction of tet methylcytosine dioxygenase 3 (TET3) activity, CpG sites across the E2F1 binding motif lose the hydroxymethylation marks while gaining the de novo methyltransferase-elicited methylation marks. These two oxygen-sensitive epigenetic events work in concert to repel E2F1 from the ESRP1 promoter, thereby diminishing ESRP1 expression under hypoxia. Furthermore, E2F1 skews the cancer spliceome by upregulating splicing factor SRSF7 in hypoxic breast cancer cells. Our findings provide previously unreported mechanistic insights into the plastic nature of ESRP1 expression and insinuate important implications in therapeutics targeting breast cancer progression.<\/jats:p>","DOI":"10.1038\/s41389-021-00347-6","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T08:02:46Z","timestamp":1628236966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression"],"prefix":"10.1038","volume":"10","author":[{"given":"Cheemala","family":"Ashok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3973-2842","authenticated-orcid":false,"given":"Subhashis","family":"Natua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jharna","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Samaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-0588","authenticated-orcid":false,"given":"Sanjeev","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"347_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016;16:413\u201330.","journal-title":"Nat Rev Cancer"},{"key":"347_CR2","doi-asserted-by":"publisher","first-page":"107390","DOI":"10.1016\/j.pharmthera.2019.07.001","volume":"203","author":"S Mohibi","year":"2019","unstructured":"Mohibi S, Chen X, Zhang J. Cancer the \u2018RBP\u2019eutics\u2013RNA-binding proteins as therapeutic targets for cancer. Pharmacol Therapeutics. 2019;203:107390.","journal-title":"Pharmacol Therapeutics"},{"key":"347_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"B Pereira","year":"2017","unstructured":"Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer. 2017;3:506\u201328.","journal-title":"Trends Cancer"},{"key":"347_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.phrs.2019.03.008","volume":"143","author":"E Buoso","year":"2019","unstructured":"Buoso E, Ronfani M, Galasso M, Ventura D, Corsini E, Racchi M. Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration. Pharmacol Res. 2019;143:17\u201326.","journal-title":"Pharmacol Res."},{"key":"347_CR5","doi-asserted-by":"publisher","first-page":"E3426","DOI":"10.1073\/pnas.1714573115","volume":"115","author":"H Ke","year":"2018","unstructured":"Ke H, Zhao L, Zhang H, Feng X, Xu H, Hao J, et al. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3. Proc Natl Acad Sci. 2018;115:E3426\u2013E3435.","journal-title":"Proc Natl Acad Sci."},{"key":"347_CR6","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1016\/j.celrep.2019.10.110","volume":"29","author":"S Park","year":"2019","unstructured":"Park S, Brugiolo M, Akerman M, Das S, Urbanski L, Geier A, et al. Differential functions of splicing factors in mammary transformation and breast cancer metastasis. Cell Rep. 2019;29:2672\u20132688. e2677.","journal-title":"Cell Rep."},{"key":"347_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1101\/gad.241968.114","volume":"28","author":"Y Xu","year":"2014","unstructured":"Xu Y, Gao XD, Lee JH, Huang H, Tan H, Ahn J, et al. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing. Genes Dev. 2014;28:1191\u2013203.","journal-title":"Genes Dev."},{"key":"347_CR8","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1158\/0008-5472.CAN-09-1852","volume":"69","author":"K Moran-Jones","year":"2009","unstructured":"Moran-Jones K, Grindlay J, Jones M, Smith R, Norman JC. hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration. Cancer Res. 2009;69:9219\u201327.","journal-title":"Cancer Res."},{"key":"347_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002218","volume":"7","author":"IM Shapiro","year":"2011","unstructured":"Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, et al. An EMT\u2013driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 2011;7:e1002218.","journal-title":"PLoS Genet"},{"key":"347_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/MCB.01174-12","volume":"33","author":"JP Venables","year":"2013","unstructured":"Venables JP, Brosseau JP, Gadea G, Klinck R, Prinos P, Beaulieu JF, et al. RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol Cell Biol. 2013;33:396\u2013405.","journal-title":"Mol Cell Biol."},{"key":"347_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/ijms21020575","volume":"21","author":"U Ala","year":"2020","unstructured":"Ala U, Manco M, Mandili G, Tolosano E, Novelli F, Provero P, et al. Proteomics-based evidence for a pro-oncogenic role of ESRP1 in human colorectal cancer cells. Int J Mol Sci. 2020;21:575.","journal-title":"Int J Mol Sci."},{"key":"347_CR12","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.18632\/oncotarget.14318","volume":"8","author":"S Fagoonee","year":"2017","unstructured":"Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, et al. The RNA-binding protein ESRP1 promotes human colorectal cancer progression. Oncotarget. 2017;8:10007\u201324.","journal-title":"Oncotarget"},{"key":"347_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01254-3","volume":"20","author":"G Deng","year":"2020","unstructured":"Deng G, Zhou X, Chen L, Yao Y, Li J, Zhang Y, et al. High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer. Cancer Cell Int. 2020;20:1\u201315.","journal-title":"Cancer Cell Int."},{"key":"347_CR14","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1038\/oncsis.2017.87","volume":"6","author":"HM Jeong","year":"2017","unstructured":"Jeong HM, Han J, Lee SH, Park HJ, Lee HJ, Choi JS, et al. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cellsThis article has been corrected since Advance Online Publication and an erratum is also printed in this issue. Oncogenesis. 2017;6:e389\u2013e389.","journal-title":"Oncogenesis"},{"key":"347_CR15","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3389\/fonc.2020.556650","volume":"10","author":"HH Lee","year":"2020","unstructured":"Lee HH, Lee AJ, Park WS, Lee J, Park J, Park B, et al. Epithelial Splicing Regulatory Protein (ESPR1) expression in an unfavorable prognostic factor in prostate cancer patients. Front Oncol. 2020;10:2274.","journal-title":"Front Oncol."},{"key":"347_CR16","doi-asserted-by":"publisher","first-page":"zcaa0","DOI":"10.1093\/narcan\/zcaa021","volume":"2","author":"N Ahuja","year":"2020","unstructured":"Ahuja N, Ashok C, Natua S, Pant D, Cherian A, Pandkar MR, et al. Hypoxia-induced TGF-\u03b2\u2013RBFOX2\u2013ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer. NAR Cancer. 2020;2:zcaa0. 221","journal-title":"NAR Cancer"},{"key":"347_CR17","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1172\/JCI44540","volume":"121","author":"RL Brown","year":"2011","unstructured":"Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Investig. 2011;121:1064\u201374.","journal-title":"J Clin Investig."},{"key":"347_CR18","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.18632\/oncotarget.13682","volume":"8","author":"P Fici","year":"2017","unstructured":"Fici P, Gallerani G, Morel AP, Mercatali L, Ibrahim T, Scarpi E, et al. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer. Oncotarget. 2017;8:2423\u201336.","journal-title":"Oncotarget"},{"key":"347_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1261\/rna.066712.118","volume":"24","author":"SE Harvey","year":"2018","unstructured":"Harvey SE, Xu Y, Lin X, Gao XD, Qiu Y, Ahn J, et al. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT. RNA. 2018;24:1326\u201338.","journal-title":"RNA"},{"key":"347_CR20","doi-asserted-by":"publisher","first-page":"27386","DOI":"10.1074\/jbc.M114.589432","volume":"289","author":"H Ishii","year":"2014","unstructured":"Ishii H, Saitoh M, Sakamoto K, Kondo T, Katoh R, Tanaka S, et al. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. J Biol Chem. 2014;289:27386\u201399.","journal-title":"J Biol Chem."},{"key":"347_CR21","doi-asserted-by":"publisher","first-page":"36435","DOI":"10.1074\/jbc.M112.397125","volume":"287","author":"LM Reinke","year":"2012","unstructured":"Reinke LM, Xu Y, Cheng C. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition. J Biol Chem. 2012;287:36435\u201342.","journal-title":"J Biol Chem."},{"key":"347_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2009.01.025","volume":"33","author":"CC Warzecha","year":"2009","unstructured":"Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell. 2009;33:591\u2013601.","journal-title":"Mol Cell"},{"key":"347_CR23","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/emboj.2010.195","volume":"29","author":"CC Warzecha","year":"2010","unstructured":"Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, et al. An ESRP\u2010regulated splicing programme is abrogated during the epithelial\u2013mesenchymal transition. EMBO J. 2010;29:3286\u20133300.","journal-title":"EMBO J."},{"key":"347_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10571-015-0226-2","volume":"36","author":"C Yang","year":"2016","unstructured":"Yang C, Li X, Mo Y, Liu S, Zhao L, Ma X, et al. \u03b2-asarone mitigates amyloidosis and downregulates RAGE in a transgenic mouse model of Alzheimer\u2019s disease. Cell Mol Neurobiol. 2016;36:121\u201330.","journal-title":"Cell Mol Neurobiol."},{"key":"347_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"8","author":"D Chandrashekar","year":"2017","unstructured":"Chandrashekar D, Bhuwan B, Sai AHB, Chad JC, Israel P-R, Balabhadrapatruni VSKC, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;8:649\u201358.","journal-title":"Neoplasia"},{"key":"347_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13528-0","volume":"10","author":"F Chen","year":"2019","unstructured":"Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019;10:1\u201315.","journal-title":"Nat Commun."},{"key":"347_CR27","doi-asserted-by":"crossref","first-page":"D87","DOI":"10.1093\/nar\/gkaa516","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48:D87\u2013D92.","journal-title":"Nucleic Acids Res."},{"key":"347_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","volume":"93","author":"M Hockel","year":"2001","unstructured":"Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 2001;93:266\u201376.","journal-title":"J. Natl Cancer Inst."},{"key":"347_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175\u201380.","journal-title":"Science"},{"key":"347_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature19081","volume":"537","author":"B Thienpont","year":"2016","unstructured":"Thienpont B, Steinbacher J, Zhao H, D'Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63\u201368.","journal-title":"Nature"},{"key":"347_CR31","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK. 5-Azacytidine and 5-aza-2\u2032-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21:5483\u201395.","journal-title":"Oncogene"},{"key":"347_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1021\/acsmedchemlett.8b00474","volume":"10","author":"G Chua","year":"2019","unstructured":"Chua G, Wassarman KL, Sun H, Alp JA, Jarczyk EI, Kuzio NJ, et al. Cytosine-based TET enzyme inhibitors. ACS Med Chem. Lett. 2019;10:180\u20135.","journal-title":"ACS Med Chem. Lett."},{"key":"347_CR33","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s00018-020-03727-0","volume":"78","author":"S Natua","year":"2021","unstructured":"Natua S, Ashok C, Shukla S. Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige. Cell Mol Life Sci. 2021;78:2729\u201347.","journal-title":"Cell Mol Life Sci"},{"key":"347_CR34","first-page":"5545","volume":"15","author":"Y Fu","year":"2018","unstructured":"Fu Y, Wang Y. SRSF7 knockdown promotes apoptosis of colon and lung cancer cells. Oncol Lett. 2018;15:5545\u201352.","journal-title":"Oncol Lett."},{"key":"347_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mcn.2006.10.004","volume":"34","author":"L Gao","year":"2007","unstructured":"Gao L, Wang J, Wang Y, Andreadis A. SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations. Mol Cell Neurosci. 2007;34:48\u201358.","journal-title":"Mol Cell Neurosci."},{"key":"347_CR36","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.febslet.2012.05.046","volume":"586","author":"J Gu","year":"2012","unstructured":"Gu J, Shi J, Wu S, Jin N, Qian W, Zhou J, et al. Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10. Febs Lett. 2012;586:2239\u201344.","journal-title":"Febs Lett."},{"key":"347_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semcancer.2012.04.003","volume":"5-6","author":"CC Warzecha","year":"2012","unstructured":"Warzecha CC, Carstens RP. Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol. 2012;5-6:417\u201327.","journal-title":"Semin Cancer Biol"},{"key":"347_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2010.09.007","volume":"300","author":"RM Gemmill","year":"2011","unstructured":"Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, et al. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011;300:66\u201378.","journal-title":"Cancer Lett."},{"key":"347_CR39","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1038\/onc.2011.493","volume":"31","author":"K Horiguchi","year":"2012","unstructured":"Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, et al. TGF-\u03b2 drives epithelial-mesenchymal transition through \u03b4EF1-mediated downregulation of ESRP. Oncogene. 2012;31:3190\u2013201.","journal-title":"Oncogene"},{"key":"347_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123:725\u201331.","journal-title":"Breast Cancer Res Treat."},{"key":"347_CR41","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102.","journal-title":"Nucleic Acids Res."},{"key":"347_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-020-01395-5","volume":"37","author":"C Ashok","year":"2020","unstructured":"Ashok C, Selvam M, Ponne S, Parcha PK, Raja K, Baluchamy S. CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6. Med Oncol. 2020;37:1\u201311.","journal-title":"Med Oncol"},{"key":"347_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0887-0","volume":"9","author":"A Gupta","year":"2018","unstructured":"Gupta A, Ajith A, Singh S, Panday RK, Samaiya A, Shukla S. PAK2\u2013c-Myc\u2013PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect. Cell Death Dis. 2018;9:1\u201315.","journal-title":"Cell Death Dis."},{"key":"347_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6257-1","volume":"19","author":"S Yadav","year":"2019","unstructured":"Yadav S, Bhagat SD, Gupta A, Samaiya A, Srivastava A, Shukla S. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer. BMC Cancer. 2019;19:1031.","journal-title":"BMC Cancer"},{"key":"347_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-020-00291-x","volume":"9","author":"M Masi","year":"2020","unstructured":"Masi M, Garattini E, Bolis M, Di Marino D, Maraccani L, Morelli E, et al. OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression. Oncogenesis. 2020;9:1\u201315.","journal-title":"Oncogenesis"},{"key":"347_CR46","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cub.2010.04.042","volume":"20","author":"B Serrels","year":"2010","unstructured":"Serrels B, Sandilands E, Serrels A, Baillie G, Houslay MD, Brunton VG, et al. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity. Curr Biol. 2010;20:1086\u201392.","journal-title":"Curr Biol."},{"key":"347_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature10442","volume":"479","author":"S Shukla","year":"2011","unstructured":"Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature. 2011;479:74\u201379.","journal-title":"Nature"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00347-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T09:04:28Z","timestamp":1675587868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00347-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1038\/s41389-021-00347-6","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}